Xylem Inc (NYSE:XYL)‘s stock had its “hold” rating restated by equities research analysts at Stifel Nicolaus in a research report issued on Thursday. They presently have a $52.00 price objective on the industrial products company’s stock. Stifel Nicolaus’ price objective points to a potential downside of 4.38% from the stock’s previous close.

A number of other research firms have also recently issued reports on XYL. Zacks Investment Research upgraded shares of Xylem from a “hold” rating to a “buy” rating and set a $62.00 target price for the company in a research note on Tuesday. BidaskClub raised shares of Xylem from a “hold” rating to a “buy” rating in a research report on Wednesday, June 28th. Oppenheimer Holdings, Inc. set a $58.00 price target on shares of Xylem and gave the company a “buy” rating in a research report on Tuesday, June 20th. BMO Capital Markets initiated coverage on shares of Xylem in a research report on Wednesday, June 21st. They issued an “outperform” rating and a $60.00 price target on the stock. Finally, Boenning Scattergood reissued a “buy” rating and issued a $55.00 price target on shares of Xylem in a research report on Wednesday, June 7th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $56.08.

Xylem (XYL) traded down 1.02% during midday trading on Thursday, hitting $54.38. 2,193,564 shares of the stock traded hands. Xylem has a 1-year low of $44.44 and a 1-year high of $55.45. The firm has a market cap of $9.77 billion, a P/E ratio of 39.12 and a beta of 1.18. The company has a 50-day moving average price of $53.05 and a 200-day moving average price of $50.40.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, May 2nd. The industrial products company reported $0.39 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.01. The firm had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Xylem had a net margin of 5.23% and a return on equity of 10.12%. The company’s revenue was up 26.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.35 earnings per share. Analysts predict that Xylem will post $2.31 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 21st. Investors of record on Thursday, May 25th were given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date of this dividend was Tuesday, May 23rd. Xylem’s dividend payout ratio (DPR) is currently 50.35%.

ILLEGAL ACTIVITY NOTICE: “Stifel Nicolaus Reiterates “Hold” Rating for Xylem Inc (NYSE:XYL)” was first published by American Banking News and is owned by of American Banking News. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/07/06/stifel-nicolaus-reiterates-hold-rating-for-xylem-inc-nysexyl.html.

In related news, Director Steven R. Loranger sold 66,132 shares of the business’s stock in a transaction on Thursday, June 29th. The shares were sold at an average price of $55.01, for a total transaction of $3,637,921.32. Following the transaction, the director now owns 65,030 shares of the company’s stock, valued at $3,577,300.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Tomas Brannemo sold 14,080 shares of the business’s stock in a transaction on Thursday, May 4th. The stock was sold at an average price of $50.36, for a total transaction of $709,068.80. Following the transaction, the insider now directly owns 21,000 shares in the company, valued at approximately $1,057,560. The disclosure for this sale can be found here. Insiders own 0.75% of the company’s stock.

A number of institutional investors have recently made changes to their positions in XYL. Asset Planning Services Ltd. raised its position in shares of Xylem by 0.3% in the first quarter. Asset Planning Services Ltd. now owns 2,107 shares of the industrial products company’s stock worth $106,000 after buying an additional 7 shares during the period. Contravisory Investment Management Inc. raised its position in shares of Xylem by 96.1% in the first quarter. Contravisory Investment Management Inc. now owns 2,345 shares of the industrial products company’s stock worth $118,000 after buying an additional 1,149 shares during the period. Cribstone Capital Management LLC raised its position in shares of Xylem by 1,214.6% in the first quarter. Cribstone Capital Management LLC now owns 2,432 shares of the industrial products company’s stock worth $124,000 after buying an additional 2,247 shares during the period. FNY Partners Fund LP bought a new position in shares of Xylem during the first quarter worth about $151,000. Finally, Pacer Advisors Inc. raised its position in shares of Xylem by 3.4% in the first quarter. Pacer Advisors Inc. now owns 3,701 shares of the industrial products company’s stock worth $186,000 after buying an additional 121 shares during the period. 85.79% of the stock is currently owned by institutional investors and hedge funds.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc and related companies with MarketBeat.com's FREE daily email newsletter.